Orthogonal Chemistry Enables Precision Nanoparticle Cofunctionalization for Tuning Immune Stimulation and Antigen...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Drug Delivery

Background:

• Combination therapies are crucial for complex diseases, but precise delivery of multiple drugs remains a challenge.
• Current methods for co-delivering drugs via nanoparticles struggle with controlling individual drug ratios and release kinetics.
• Optimizing drug ratios and release is essential for maximizing therapeutic synergy and patient outcomes.

Purpose of the Study:

• To develop a versatile drug delivery platform enabling chemistry-defined control over the conjugation ratio and release behavior of co-delivered drugs.
• To address limitations in current nanoparticle-based combination therapy delivery systems.
• To demonstrate the platform's utility in modulating immune responses as a subunit vaccine.

Main Methods:

• Utilizing thiol-disulfide exchange and strain-promoted click chemistry for controlled drug conjugation.
• Employing an established polymeric nanoparticle platform for drug encapsulation and delivery.
• Evaluating the platform's efficacy in modulating dendritic cell maturation and antigen presentation in lymph nodes.

Main Results:

• Achieved precise control over the conjugation ratio and release profiles of co-delivered therapeutic moieties.
• Demonstrated successful application of the platform as a subunit vaccine, modulating immune cell activity.
• Overcame key challenges associated with optimizing combination therapy delivery using a single carrier.

Conclusions:

• The developed dual-functional drug delivery platform offers a versatile solution for advanced combination therapies.
• Precise control over drug ratios and release enhances therapeutic potential and opens new avenues for vaccine design.
• This system represents a significant advancement in overcoming existing hurdles in multi-drug delivery systems.